Malignant Disease Flashcards
Factors contributing to poor prognosis in ALL
Age: <1y, >10y
WCC: >50
Genetic/molecular: MLL rearrangement, t(4;11), hypodiploidy
Response to initial chemo: leukaemic blasts persist in BM
MRD assessment: high
ALL new Dx No CNS
Induction chemo Dexrazone (prev. cardiotox from doxoribicin) Rituximab if CD20+ Trk Inhibs (imatinib for t9;22) Additional: - fluid therapy + allopurinol - proph. Abx - norethistrone to suppress periods Correct anaemia using trx if necessary
Induction chemotherapy in ALL
pred
vincristine
anthracyclines and/or L-asparginase
Remission in ALL
leukaemic blasts eradicated and normal BM function
ALL w/CNS involvement
Cytotoxics penetrate CNS poorly
Intrathecal chemotherappy req. to prevent CNS
Continuing chemotherapy of moderate intensity usually continued for up to 3y
High dose chemo +/- total body irradiation followed by BMT is alternative to chemo after a relapse
Brain tumours in children
surgery (prevent hydrocephalus, tissue diagnosis, maximum resection)
radio/chemo
Lymphoma in children
chemo +/- radio
PET monitors Rx
80% cure rate
Neuroblastoma in children
most common extra-cranial tumour in children
localised primaries w/o mets can be cured by surgery alone
In some infants neuroblastoma can resolve spontaenously
Metastatic dx in older children Mx w/chemo
High dose therapy w/autologous sc rescue, surgery and radio
High risk of relapse
cure rate for metastatic is 40%
Wilm’s tumour
Surgery and chemo
subsequent managament dependent on histology
5% bilat.
>80% are cured
Retinoblastoma`
average age 18m Aim to cure but preserve vision chemo to shrink laser treatment of retina radio if advanced 90% cured many visually impaired, some req enucleation significant risk of second malig. (sarcoma) in survivors of hereditary RB
Soft tissue sarcoma
chemo, radio, surgery
65% cure
Bone tumours
chemo, radio, surgery
65% cure
Germ cell tumour
highly chemo sens
good prognosis